The HCPLive Infectious Disease condition center page is a comprehensive resource for clinical news and insights on respiratory health. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for asthma, COPD, interstitial lung disease, COVID-19, and more.
April 20th 2024
In this Q&A, Kathuria explains the current state of smoking cessation programs and how health care providers can help patients combat their tobacco dependence.
Addressing Healthcare Inequities: Tailoring Management Plans to Address Healthcare Disparities in Cystic Fibrosis
View More
Revolutionizing Early-Stage NSCLC Treatment: Pathologists’ Key Insights into Predicting Pathologic Responses to Immunotherapies
View More
Community Practice Connections™: 20th Annual Winter Lung Conference
View More
Medical Crossfire®: Key Strategies to Prioritize Testing and the Evolving Role of Genomic Alterations in Providing Precision NSCLC Care
View More
Breaking Down Biomarkers in Non–Small Cell Lung Cancer: A Case-Based Discussion for the Oncology Nurse
View More
Go To PER in Chicago
May 31, 2024 - June 2, 2024
Register Now!
The Top 10 Oncogenic Drivers in NSCLC for 2023: What You Need to Know on Tumor Testing, Targets, and Treatment Strategies to Move the Field Forward
View More
Respiratory Syncytial Virus: Understanding the Infection Burden and Anticipating the Impact of Vaccines
View More
Engaging the Multidisciplinary Care Team to Optimize Care of Patients With EGFR Mutation–Positive NSCLC: A Lung Cancer Tumor Board
View More
Expanding the Armamentarium of Actionable Mutations in NSCLC: Uncovering the Potential of CEACAM5 as a Therapeutic Target
View More
25th Annual International Lung Cancer Congress®
July 25-27, 2024
Register Now!
24th Annual International Lung Cancer Congress®
View More
Engaging the Multidisciplinary Care Team to Optimize Care of Patients With EGFR Mutation-Positive NSCLC: A Lung Cancer Tumor Board
View More
Pathology Implications for CEACAM5 as a Therapeutic Target in Advanced NSCLC
View More
Medical Crossfire®: What Are Effective Strategies for Onco-Nurses to Improve Outcomes in Patients with Small Cell Lung Cancer?
View More
Advances In™: Aligning Pathology and Oncology Efforts in the Community to Improve NSCLC Care
View More
Community Practice Connections: 7th Annual School of Nursing Oncology™
View More
6th Annual Precision Medicine Symposium: An Illustrated Tumor Board
October 18-19, 2024
Register Now!
Virtual Show Me the Data™: How HER2, HER3, and TROP2 Targeted Strategies Will Impact Evolving Paradigms in NSCLC
View More
6th Annual Advanced Practice Collaborative
View More
Community Practice Connections™: 24th Annual International Lung Cancer Congress®
View More
42nd Annual CFS®: Innovative Cancer Therapy for Tomorrow®
November 13-15, 2024
Register Now!
19th Annual New York Lung Cancers Symposium®
November 16, 2024
Register Now!
Let’s Get “Real”: Alpha-1 Antitrypsin Deficiency—Case-Based Perspectives on Managing Associated Emphysema
View More
Shaping the Management of COPD with Biologic Therapy
View More
Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes
View More
EGPA: Highlighting the Patient Journey to Improve the Differential Diagnosis and Accelerate the Initiation of Guideline-Based Care
View More
Identifying Actionable Biomarkers in NSCLC: Real World Case Discussions on Applications of Testing in the Treatment Planning Process
View More
How CEACAM5 Expression Can Be Measured and Leveraged in NSCLC Care: Current Developments & Future Therapeutic Opportunities
View More
Lung Cancer Tumor Board®: Enhancing Multidisciplinary Communication to Optimize Immunotherapy in Stage I-III NSCLC
View More
Nicotine Withdrawal Weakens Brain Interconnectivity while Quitting Smoking
As evidenced in brain scans after abstaining from smoking for 24 hours, smokers were likely to show weakened interconnectivity between brain networks, according to a study published in JAMA Psychiatry.
American Academy of Allergy, Asthma & Immunology
March 7th 2014The annual meeting of the American Academy of Allergy, Asthma & Immunology was held from Feb. 28 to March 4 in San Diego and attracted more than 5,000 participants from around the world, including clinicians, academicians, allied health professionals, and others interested in allergic and immunologic disease. The conference highlighted recent advances in allergy, asthma, and immunology.
Can a Smoking Cessation Drug Cause Neuropsychiatric Adverse Events?
March 7th 2014When encouraging and supporting patients to quit smoking, varenicline is unlikely to increase the risk of neuropsychiatric adverse events such as suicide, depression, and aggression, even in patients with pre-existing psychiatric illness.
Asthma vs. COPD: Does the Diagnosis Matter in the Clinic When Designing a Management Plan?
March 5th 2014Do asthma and COPD share enough characteristics such as reduced rate of airflow resulting from increased inflammation, along with similar responses to some forms of treatment, reduce the importance of differential diagnosis?
Personalized Medicine and the Role of Biologics in Severe Chronic Rhinosinusitis
March 5th 2014Research into the pathogenesis of chronic rhinosinusitis has shed new light on the association between asthma and CRS while also providing new insight into CRS disease endotypes, enabling clinicians to individualize treatment regimens.
Pre-Op Intra-Aortic Balloon Pumps Improve Coronary Artery Bypass Grafting Results
February 25th 2014Though most studies on the preoperative use of intra-aortic balloon pumps in coronary artery bypass grafting patients have reported early results, they have not been able to determine long-term outcomes.
In Patients Hospitalized for Heart Failure, Hyponatremia Predicts Complications, But Not Mortality
February 18th 2014In a real-world sample of patients hospitalized for heart failure (HF), hyponatremia predicted clinical complications during admission, but it was not linked to short-term mortality or readmission.
Where There's Vapor, Is There Fire?
February 12th 2014Because e-cigarettes are marketed as a "safer alternative to tobacco smoking," concerns have surfaced regarding the potential for long-term health consequences that stem from inhaling vapor containing nicotine, propylene glycol, and by-products, as well as exposing bystanders to the substance second-hand.